NEW YORK (GenomeWeb News) – German firm MoBiTec today announced a distribution deal in Germany for BellBrook Labs' high-throughput screening platform for enzymes.
Financial and other terms of the deal were not disclosed.
BellBrooks Labs' Transcreener HTS Assays is a high-throughput screening platform for enzymes based on direct detection of nucleotide enzyme products with far red fluorescence intensity, fluorescence polarization, and time resolved-fluorescence resonance energy transfer readouts, MoBiTec said. It added that the system allows for the screening of more targets, both well-characterized and emerging, more quickly and more efficiently.
The Transcreener assay method can also be used across entire families of nucleotide-dependent enzymes.
Based in Madison, Wis., BellBrook provides screening tools in order to accelerate new drug discovery work. Thermo Fisher Scientific said last month it would distribute the firm's array products.
MoBiTec offers research tools for molecular and cellular biology research.